Asston Pharmaceuticals IPO GMP Today | Price, Allotment & Listing Update 2025

Asston Pharmaceuticals IPO GMP is drawing investor attention as this SME pharma company prepares to go public. With a strong foothold in pharmaceutical formulations and nutraceuticals, Asston Pharmaceuticals Limited is launching its SME IPO to raise capital for business expansion, research & development, and working capital requirements.

The Asston Pharmaceuticals IPO opens on 9 July 2025 and closes on 11 July 2025. The IPO is worth ₹27.56 crores and includes a fresh issue of 22.41 lakh equity shares. The IPO price band is set at ₹115 to ₹123 per share, and the shares are expected to be listed on the BSE SME platform on Wednesday, 16 July 2025.

Asston Pharmaceuticals IPO – Key Details

Particulars - Information
IPO Opening Date
9 July 2025 (Wednesday)
IPO Closing Date
11 July 2025 (Friday)
Issue Size
₹27.56 Crores
Fresh Issue
22.41 lakh shares
Price Band
₹115 to ₹123 per share

Issue Type
Book Built Issue – SME IPO
Listing Exchange
BSE SME Platform
Expected Listing Date
16 July 2025 (Wednesday)

Asston Pharmaceuticals IPO GMP Trend
Investors are closely tracking the Asston Pharmaceuticals IPO GMP (Grey Market Premium) to estimate possible listing gains. As of now, the IPO GMP is showing moderate to positive traction, hinting at decent demand in the unlisted space.

While GMP is unofficial, it reflects early sentiment from retail and HNI investors. The company’s strong product portfolio, WHO-GMP-certified facility, and presence in both domestic and international markets are key factors fueling investor interest.

???? Reminder: GMP is not a guarantee of listing success. It should be evaluated alongside company fundamentals and valuations.
About Asston Pharmaceuticals Limited

Asston Pharmaceuticals Limited is a growing player in the pharma and nutraceutical industry. The company manufactures a wide range of dosage forms, including:
Tablets
Capsules
Syrups
Topical formulations

Its competitive edge lies in:
A modern WHO-GMP compliant facility
A technically sound and experienced management team
An expanding distribution network across markets
With rising demand for affordable healthcare and wellness products, Asston is well-positioned for long-term growth.

Should You Apply for the Asston Pharmaceuticals IPO?

For retail investors and HNIs, this IPO presents an opportunity to invest in a niche pharma company with expansion potential. If the Asston Pharmaceuticals IPO GMP continues to stay positive, the listing could deliver short-term gains. However, being an SME IPO, risk appetite and portfolio diversification should be carefully considered.

Final Thoughts

The Asston Pharmaceuticals IPO GMP is being watched closely by market participants hoping for solid listing performance. With the pharma sector showing resilience and IPO activity picking up in 2025, this issue could prove to be a hidden gem for early investors.

Stay updated with Finowings for real-time GMP trends, subscription updates, allotment status, and expert IPO analysis. Make smarter investment decisions with India’s fastest-growing financial platform.